CN103997899B - 益生菌组合物和方法 - Google Patents
益生菌组合物和方法 Download PDFInfo
- Publication number
- CN103997899B CN103997899B CN201280040658.4A CN201280040658A CN103997899B CN 103997899 B CN103997899 B CN 103997899B CN 201280040658 A CN201280040658 A CN 201280040658A CN 103997899 B CN103997899 B CN 103997899B
- Authority
- CN
- China
- Prior art keywords
- cbal74
- lactobacillus paraceasi
- purposes
- cfu
- foodstuff products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 142
- 238000000034 method Methods 0.000 title claims abstract description 78
- 239000006041 probiotic Substances 0.000 title abstract description 21
- 230000000529 probiotic effect Effects 0.000 title abstract description 21
- 235000018291 probiotics Nutrition 0.000 title abstract description 21
- 241000186660 Lactobacillus Species 0.000 claims abstract description 266
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 265
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 40
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 33
- 210000000987 immune system Anatomy 0.000 claims abstract description 32
- 230000036039 immunity Effects 0.000 claims abstract description 15
- 201000010099 disease Diseases 0.000 claims abstract description 14
- 230000001105 regulatory effect Effects 0.000 claims abstract description 4
- 238000000855 fermentation Methods 0.000 claims description 80
- 230000004151 fermentation Effects 0.000 claims description 80
- 239000008267 milk Substances 0.000 claims description 76
- 210000004080 milk Anatomy 0.000 claims description 76
- 235000013336 milk Nutrition 0.000 claims description 75
- 240000007594 Oryza sativa Species 0.000 claims description 57
- 235000007164 Oryza sativa Nutrition 0.000 claims description 57
- 235000009566 rice Nutrition 0.000 claims description 57
- 241000894006 Bacteria Species 0.000 claims description 50
- 208000035475 disorder Diseases 0.000 claims description 24
- 230000007547 defect Effects 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 18
- 241000194017 Streptococcus Species 0.000 claims description 16
- 235000011868 grain product Nutrition 0.000 claims description 16
- 208000004262 Food Hypersensitivity Diseases 0.000 claims description 15
- 206010016946 Food allergy Diseases 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 15
- 235000020932 food allergy Nutrition 0.000 claims description 14
- 230000000050 nutritive effect Effects 0.000 claims description 13
- 230000002757 inflammatory effect Effects 0.000 claims description 12
- 239000002054 inoculum Substances 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 11
- 206010012735 Diarrhoea Diseases 0.000 claims description 10
- 239000003937 drug carrier Substances 0.000 claims description 10
- 208000011231 Crohn disease Diseases 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 9
- 240000005979 Hordeum vulgare Species 0.000 claims description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 8
- 206010051606 Necrotising colitis Diseases 0.000 claims description 8
- 230000002519 immonomodulatory effect Effects 0.000 claims description 8
- 208000004995 necrotizing enterocolitis Diseases 0.000 claims description 8
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 claims description 8
- 235000013311 vegetables Nutrition 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000035479 physiological effects, processes and functions Effects 0.000 claims description 7
- 230000009385 viral infection Effects 0.000 claims description 7
- 235000007319 Avena orientalis Nutrition 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 6
- 235000013350 formula milk Nutrition 0.000 claims description 6
- 235000007558 Avena sp Nutrition 0.000 claims description 5
- 235000013351 cheese Nutrition 0.000 claims description 5
- -1 particulate Substances 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 206010012559 Developmental delay Diseases 0.000 claims description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 241000209056 Secale Species 0.000 claims description 3
- 235000007238 Secale cereale Nutrition 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 244000062793 Sorghum vulgare Species 0.000 claims description 3
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 claims description 3
- 235000019714 Triticale Nutrition 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000019713 millet Nutrition 0.000 claims description 3
- 241000228158 x Triticosecale Species 0.000 claims description 3
- 235000013618 yogurt Nutrition 0.000 claims description 3
- 208000015943 Coeliac disease Diseases 0.000 claims 5
- 241000209763 Avena sativa Species 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 2
- 238000003149 assay kit Methods 0.000 claims 2
- 241000186605 Lactobacillus paracasei Species 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 239000000693 micelle Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 25
- 244000005700 microbiome Species 0.000 abstract description 6
- 239000000047 product Substances 0.000 description 76
- 210000004443 dendritic cell Anatomy 0.000 description 57
- 210000004027 cell Anatomy 0.000 description 55
- 241000699666 Mus <mouse, genus> Species 0.000 description 53
- 210000004347 intestinal mucosa Anatomy 0.000 description 38
- 102000003814 Interleukin-10 Human genes 0.000 description 30
- 108090000174 Interleukin-10 Proteins 0.000 description 30
- 230000000694 effects Effects 0.000 description 30
- 239000013589 supplement Substances 0.000 description 30
- 210000004698 lymphocyte Anatomy 0.000 description 28
- 102000004388 Interleukin-4 Human genes 0.000 description 27
- 108090000978 Interleukin-4 Proteins 0.000 description 27
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 26
- 235000005911 diet Nutrition 0.000 description 26
- 102000004127 Cytokines Human genes 0.000 description 25
- 108090000695 Cytokines Proteins 0.000 description 25
- 230000037213 diet Effects 0.000 description 25
- 235000020183 skimmed milk Nutrition 0.000 description 24
- 210000004400 mucous membrane Anatomy 0.000 description 23
- 230000008569 process Effects 0.000 description 23
- 238000012360 testing method Methods 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 20
- 241001465754 Metazoa Species 0.000 description 16
- 239000000758 substrate Substances 0.000 description 16
- 230000003110 anti-inflammatory effect Effects 0.000 description 15
- 230000008859 change Effects 0.000 description 15
- 239000000843 powder Substances 0.000 description 15
- 230000002779 inactivation Effects 0.000 description 14
- 230000006698 induction Effects 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 230000000770 proinflammatory effect Effects 0.000 description 14
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 13
- 102000003777 Interleukin-1 beta Human genes 0.000 description 13
- 108090000193 Interleukin-1 beta Proteins 0.000 description 13
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 13
- 235000013339 cereals Nutrition 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 13
- 230000014509 gene expression Effects 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000001967 plate count agar Substances 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 210000001986 peyer's patch Anatomy 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 210000001744 T-lymphocyte Anatomy 0.000 description 10
- 238000011081 inoculation Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000001954 sterilising effect Effects 0.000 description 10
- 102100037850 Interferon gamma Human genes 0.000 description 9
- 108010074328 Interferon-gamma Proteins 0.000 description 9
- 102000000536 PPAR gamma Human genes 0.000 description 9
- 108010016731 PPAR gamma Proteins 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 230000009977 dual effect Effects 0.000 description 8
- 210000000936 intestine Anatomy 0.000 description 8
- 239000003981 vehicle Substances 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 7
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000003636 conditioned culture medium Substances 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 235000013312 flour Nutrition 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 230000001502 supplementing effect Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 241000193403 Clostridium Species 0.000 description 5
- 241001135265 Cronobacter sakazakii Species 0.000 description 5
- 102000013462 Interleukin-12 Human genes 0.000 description 5
- 108010065805 Interleukin-12 Proteins 0.000 description 5
- 102000003896 Myeloperoxidases Human genes 0.000 description 5
- 108090000235 Myeloperoxidases Proteins 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 241000607142 Salmonella Species 0.000 description 5
- 241000194020 Streptococcus thermophilus Species 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 238000003501 co-culture Methods 0.000 description 5
- 235000015140 cultured milk Nutrition 0.000 description 5
- 230000009849 deactivation Effects 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 235000011194 food seasoning agent Nutrition 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- 235000009854 Cucurbita moschata Nutrition 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 239000004278 EU approved seasoning Substances 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 108010057466 NF-kappa B Proteins 0.000 description 4
- 102000003945 NF-kappa B Human genes 0.000 description 4
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 4
- 102100033117 Toll-like receptor 9 Human genes 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 235000008452 baby food Nutrition 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 210000001616 monocyte Anatomy 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000012797 qualification Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000002893 slag Substances 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- 235000000832 Ayote Nutrition 0.000 description 3
- 240000004244 Cucurbita moschata Species 0.000 description 3
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 3
- 208000005577 Gastroenteritis Diseases 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 240000004713 Pisum sativum Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 244000078534 Vaccinium myrtillus Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000017160 establishment of lymphocyte polarity Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 230000007365 immunoregulation Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 235000015136 pumpkin Nutrition 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 2
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 2
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 241000224432 Entamoeba histolytica Species 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 102000002689 Toll-like receptor Human genes 0.000 description 2
- 108020000411 Toll-like receptor Proteins 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 241000607734 Yersinia <bacteria> Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000003040 circulating cell Anatomy 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000139 costimulatory effect Effects 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 235000005489 dwarf bean Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229940007078 entamoeba histolytica Drugs 0.000 description 2
- 239000012055 enteric layer Substances 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013569 fruit product Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000005095 gastrointestinal system Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000001524 infective effect Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 235000008960 ketchup Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000004876 tela submucosa Anatomy 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000010167 Allium cepa var aggregatum Nutrition 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000010082 Averrhoa carambola Nutrition 0.000 description 1
- 240000006063 Averrhoa carambola Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001416153 Bos grunniens Species 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 241000219192 Brassica napus subsp. rapifera Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241001674939 Caulanthus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 240000006122 Chenopodium album Species 0.000 description 1
- 235000009344 Chenopodium album Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- 235000003949 Cucurbita mixta Nutrition 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- 206010061958 Food Intolerance Diseases 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 241001646541 Haustrum Species 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- NHTGHBARYWONDQ-JTQLQIEISA-N L-α-methyl-Tyrosine Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C=C1 NHTGHBARYWONDQ-JTQLQIEISA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 239000001968 M17 agar Substances 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 235000015622 Pisum sativum var macrocarpon Nutrition 0.000 description 1
- 244000148807 Pisum sativum var. macrocarpon Species 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000002357 Ribes grossularia Nutrition 0.000 description 1
- 244000171263 Ribes grossularia Species 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000016911 Ribes sativum Nutrition 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- 235000016897 Ribes triste Nutrition 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000004240 Triticum spelta Nutrition 0.000 description 1
- 240000003834 Triticum spelta Species 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000005072 Vigna sesquipedalis Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000033289 adaptive immune response Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009455 aseptic packaging Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000015179 biltong Nutrition 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 235000012777 crisp bread Nutrition 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical group O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000005014 ectopic expression Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 238000011207 functional examination Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000007919 giant pumpkin Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 235000019692 hotdogs Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 210000005007 innate immune system Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 210000005210 lymphoid organ Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 235000021278 navy bean Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000007112 pro inflammatory response Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 208000024981 pyrosis Diseases 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 210000003289 regulatory T cell Anatomy 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000003997 social interaction Effects 0.000 description 1
- 239000007886 soft shell capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
- A23C9/1275—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss using only lactobacteriaceae for fermentation in combination with enzyme treatment of the milk product; using enzyme treated milk products for fermentation with lactobacteriaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pediatric Medicine (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (70)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161498910P | 2011-06-20 | 2011-06-20 | |
US61/498,910 | 2011-06-20 | ||
PCT/US2012/042959 WO2012177556A2 (en) | 2011-06-20 | 2012-06-18 | Probiotic compositions and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103997899A CN103997899A (zh) | 2014-08-20 |
CN103997899B true CN103997899B (zh) | 2016-04-20 |
Family
ID=47423159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280040658.4A Active CN103997899B (zh) | 2011-06-20 | 2012-06-18 | 益生菌组合物和方法 |
Country Status (17)
Country | Link |
---|---|
US (4) | US10039296B2 (zh) |
EP (2) | EP3366143A1 (zh) |
JP (1) | JP2014516589A (zh) |
CN (1) | CN103997899B (zh) |
AU (1) | AU2012273206B2 (zh) |
BR (2) | BR112013032426B1 (zh) |
CA (1) | CA2839524C (zh) |
DK (1) | DK2734049T3 (zh) |
ES (1) | ES2677850T3 (zh) |
HK (1) | HK1199694A1 (zh) |
MX (1) | MX352677B (zh) |
MY (2) | MY187589A (zh) |
PL (1) | PL2734049T3 (zh) |
PT (1) | PT2734049T (zh) |
RU (2) | RU2748839C2 (zh) |
TR (1) | TR201809987T4 (zh) |
WO (1) | WO2012177556A2 (zh) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8518903B2 (en) | 2007-04-19 | 2013-08-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Use of toll-like receptor-9 agonists |
US10668092B2 (en) | 2010-09-24 | 2020-06-02 | The John Hopkins University | Compositions and methods for treatment of inflammatory disorders |
US9072760B2 (en) | 2010-09-24 | 2015-07-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders |
WO2012088425A2 (en) | 2010-12-22 | 2012-06-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease |
US10039296B2 (en) | 2011-06-20 | 2018-08-07 | H.J. Heinz Company Brands Llc | Probiotic compositions and methods |
PT2861242T (pt) * | 2012-06-18 | 2018-11-07 | Heinz Co Brands H J Llc | Disfunções relacionadas com o glúten |
WO2014052453A1 (en) * | 2012-09-25 | 2014-04-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Oral therapy of necrotizing enterocolitis |
MX2013012618A (es) * | 2012-10-26 | 2016-05-26 | María Del Carmen Cadena Garcia | Método de manufactura de mezcla de granos fermentados. |
CA2911496C (en) * | 2013-05-10 | 2023-08-22 | H.J. Heinz Company Brands Llc | Probiotics and methods of use |
ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
CN104894021B (zh) * | 2015-06-03 | 2018-02-09 | 宜兰食品工业股份有限公司 | 一种副干酪乳杆菌及其应用 |
JP6605319B2 (ja) * | 2015-12-17 | 2019-11-13 | 株式会社ダイワ | 乳酸菌含有加工食品の製造方法 |
MA45288A (fr) * | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
IT201600081929A1 (it) * | 2016-08-03 | 2018-02-03 | St Europeo Di Oncologia S R L | Uso del surnatante di lactobacillus paracasei nel trattamento della congiuntivite, in particolare della vernal cheratocongiuntivite |
IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
CN110741073A (zh) * | 2017-06-09 | 2020-01-31 | 曾根农场股份公司 | 新乳酸菌及其用途 |
SG11201913653RA (en) * | 2017-07-31 | 2020-01-30 | Mitsubishi Corporation Life Sciences Ltd | Thickening composition for dysphagia patients |
CN109662259B (zh) * | 2017-10-16 | 2022-07-29 | 江苏省农业科学院 | 一种富益生菌冻干毛豆粒产品及其制备方法 |
CN109864270B (zh) * | 2017-12-01 | 2022-07-29 | 江苏省农业科学院 | 一种富益生菌冻干胡萝卜丁产品及其制备方法 |
US20210040440A1 (en) * | 2018-02-07 | 2021-02-11 | White Dog Labs, Inc. | An improved method for selecting microorganisms |
JP2019149977A (ja) * | 2018-03-05 | 2019-09-12 | 今野 由梨 | ペット用サプリメント及びその製造方法 |
BR112020022749A2 (pt) | 2018-05-09 | 2021-03-02 | Ko Biolabs, Inc. | cepa de lactobacillus paracasei e uso da mesma |
CN113163835A (zh) * | 2019-05-15 | 2021-07-23 | N·V·努特里奇亚 | 促进肠道发育的发酵配方物 |
CN112869169B (zh) * | 2019-11-29 | 2023-07-18 | 内蒙古伊利实业集团股份有限公司 | 副干酪乳杆菌et-22提升肠道细菌感染抗性和肠道免疫力的应用 |
IT202200013882A1 (it) * | 2022-07-04 | 2024-01-04 | Alfasigma Spa | Prodotto di fermentazione per il trattamento di malattie infiammatorie. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0130228A1 (en) * | 1983-07-01 | 1985-01-09 | Microlife Technics, Inc. | Fermentation method using a selected lactobacillus |
US6599504B1 (en) * | 1997-12-08 | 2003-07-29 | Arla Ekonomisk Forening | Strain of bacteria of the species Lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain |
WO2007140622A1 (en) * | 2006-06-09 | 2007-12-13 | Nutravital Inc. | Dairy-derived probiotic compositions and uses thereof |
WO2008003782A1 (en) * | 2006-07-07 | 2008-01-10 | Alpro Nv | Method for preparing a dairy analogue |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635199A (en) | 1995-10-27 | 1997-06-03 | Nestec Ltd. | Support of pediatric patients |
RU2134583C1 (ru) | 1996-02-29 | 1999-08-20 | Санкт-Петербургская государственная педиатрическая медицинская академия | Способ санации женщин с массивной микробной обсемененностью грудного молока |
AU3173497A (en) | 1996-06-21 | 1998-01-14 | Quest International B.V. | Fermentation of fruit products |
EP0862863B9 (en) | 1997-01-09 | 2009-08-12 | Societe Des Produits Nestle S.A. | Cereal product containing probiotics |
RU2214258C2 (ru) | 1997-07-05 | 2003-10-20 | Сосьете Де Продюи Нестле С.А. | Всасывание минеральных веществ кишечными клетками |
US6036985A (en) | 1998-04-03 | 2000-03-14 | Nestec S.A. | Calcium complex and food fortified therewith |
EP1034787A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
EP1034788A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
SE522747C2 (sv) | 1999-11-18 | 2004-03-02 | Probi Ab | Barnmatsprodukt |
ATE357854T1 (de) | 2000-02-17 | 2007-04-15 | Wyeth Corp | Prebiotische substanzen enthaltende ernährungszusammensetzungen |
FI110668B (fi) | 2000-06-20 | 2003-03-14 | Aboatech Ab Oy | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
SE0003100D0 (sv) * | 2000-09-01 | 2000-09-01 | Probi Ab | New strains |
EP1322318B1 (en) | 2000-10-06 | 2010-12-08 | Nestec S.A. | Use of probiotic lactic acid bacteria for preventing ultraviolet radiation induced inflammatory or allergic reaction or immunosuppression in the skin |
GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
KR100419132B1 (ko) | 2000-12-29 | 2004-02-18 | 조성근 | 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:h7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이csk 01 |
CA2475972C (en) | 2002-02-14 | 2017-07-11 | Felix Hausch | Enzyme treatment of foodstuffs for celiac sprue |
RU2309760C2 (ru) | 2002-02-21 | 2007-11-10 | Сосьете Де Продюи Нестле С.А. | Композиция для фотопротекции кожи |
EP1364586A1 (en) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
AU2003242763B2 (en) | 2002-06-28 | 2008-02-21 | Biosearch, S.A. | Probiotic strains, a process for the selection of them, compositions thereof, and their use |
PT1638416E (pt) | 2003-06-23 | 2013-07-08 | Nestec Sa | Utilização de uma fórmula nutricional para função de barreira intestinal óptima |
BRPI0415480B1 (pt) | 2003-10-16 | 2019-09-17 | Nestec S.A. | Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia |
RU2373769C2 (ru) | 2003-10-24 | 2009-11-27 | Н.В. Нютрисиа | Синбиотическая композиция для детей |
US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
EP1723951A1 (en) | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1629850B2 (en) | 2004-08-24 | 2013-05-22 | N.V. Nutricia | Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides |
EP1855550B1 (en) | 2005-02-28 | 2011-10-05 | N.V. Nutricia | Nutritional composition with probiotics |
CN101193559A (zh) | 2005-04-13 | 2008-06-04 | 雀巢技术公司 | 具有益生菌的婴儿配方食品 |
US20060233772A1 (en) | 2005-04-15 | 2006-10-19 | Udo Herz | Method for preventing or treating the development of respiratory allergies |
EP1714660A1 (en) | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
US8075934B2 (en) | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
CN101212911B (zh) | 2005-07-01 | 2012-12-05 | 努特里希亚公司 | 含水解的蛋白质的婴儿营养品 |
AU2006323689B2 (en) | 2005-12-08 | 2012-11-08 | Kirin Holdings Kabushiki Kaisha | Isohumulone compound clathrate and composition containing the same |
ATE551063T1 (de) | 2006-02-15 | 2012-04-15 | Nestec Sa | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen |
US9005682B2 (en) | 2006-03-07 | 2015-04-14 | Nestec S.A. | Synbiotic mixture |
EP1847180A3 (en) | 2006-03-27 | 2008-04-02 | Nestec S.A. | Protein-enriched frozen dessert |
CN101511206B (zh) | 2006-07-13 | 2013-07-17 | 雀巢产品技术援助有限公司 | 用于液体营养组合物的稳定剂系统 |
ES2560666T3 (es) | 2006-08-08 | 2016-02-22 | Nestec S.A. | Composiciones estables y biodisponibles que contienen isómeros de carotenoides para la piel y el cabello |
EP1917960A1 (en) | 2006-11-06 | 2008-05-07 | Nestec S.A. | Improved biological effects of rosmarinic acid |
EP1932437A1 (en) | 2006-12-15 | 2008-06-18 | Nestec S.A. | Infant formula |
EP1972207B1 (en) | 2007-03-21 | 2018-02-28 | Nestec S.A. | Safety System For Powdered Nutritional Compositions |
EP1974743A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
EP1974735A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Reduction of risk of diarrhoea |
EP1974734A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
WO2008153377A1 (en) | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
EP2187766B1 (en) | 2007-09-07 | 2013-10-23 | Nestec S.A. | Range of aseptically produced infant foods having low concentrations of undesired by-products and methods for making the same |
PT2036447E (pt) | 2007-09-07 | 2010-03-23 | Nestec Sa | Processo para a produção de produtos alimentares para bebés |
EP2036568A1 (en) | 2007-09-12 | 2009-03-18 | Nestec S.A. | Wolfberries and inflammation |
AU2008324105B2 (en) | 2007-11-08 | 2014-01-30 | Société des Produits Nestlé S.A. | Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates |
EP2060257A1 (en) | 2007-11-08 | 2009-05-20 | Nestec S.A. | Prevention and treatment of secondary infections following viral infection |
WO2009067000A1 (en) | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2476322A3 (en) | 2007-11-26 | 2015-02-25 | Nestec S.A. | Age-tailored nutrition system for infants |
CN101451158A (zh) | 2007-12-04 | 2009-06-10 | 黑龙江大学 | 副干酪乳杆菌产生的抗菌肽的分离纯化方法 |
EP2072052A1 (en) | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
CN101977518B (zh) | 2008-01-24 | 2012-10-31 | 雀巢产品技术援助有限公司 | 容纳有营养配料的胶囊和从胶囊中分送营养液体的方法 |
EP2096115A1 (en) | 2008-02-26 | 2009-09-02 | Nestec S.A. | Oligosaccharide ingredient |
AU2009224814B2 (en) | 2008-03-14 | 2015-02-05 | Société des Produits Nestlé S.A. | Synbiotic mixture |
EP2110027A1 (en) | 2008-04-01 | 2009-10-21 | Nestec S.A. | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation |
FR2930406B1 (fr) | 2008-04-29 | 2011-04-15 | Groupe Lactalis | Aliment infantile a base de matiere grasse d'origine laitiere |
EP2143341A1 (en) | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nutritional Composition Containing Oligosaccharide Mixture |
WO2009144137A1 (en) | 2008-05-27 | 2009-12-03 | Nestec S.A. | Probiotics to improve gut microbiota |
WO2009151315A1 (en) | 2008-06-13 | 2009-12-17 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
EP2138187A1 (en) | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and infection |
WO2010002241A1 (en) | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
EP2143340A1 (en) | 2008-07-07 | 2010-01-13 | Nestec S.A. | A nutritional composition with free amino acids and structured lipids |
WO2010003878A1 (en) | 2008-07-08 | 2010-01-14 | Nestec S.A. | Portion-controlled nutrition system and method using capsules |
WO2010008272A1 (en) | 2008-07-15 | 2010-01-21 | N.V. Nutricia | Treatment of gut motility disorders |
EP2147678A1 (en) | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotics to increase IgA secretion in infants born by caesarean section |
BRPI0919409A2 (pt) | 2008-09-19 | 2015-12-15 | Nestec Sa | suporte nutricional para prevenir ou moderar a neutropenia ou paralisia da medula óssea durante o tratamento anticâncer |
EP2168444A1 (en) | 2008-09-24 | 2010-03-31 | Nestec S.A. | Acidified nutritional formula |
AU2009319257B2 (en) | 2008-11-03 | 2014-10-09 | Société des Produits Nestlé S.A. | A nutritional composition comprising probiotics and improving sleep patterns |
EP2452574A1 (en) | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional formula with particularly adapted caloric density for young infants |
US9462821B2 (en) | 2008-12-08 | 2016-10-11 | Nestec S.A. | Modulation of infant fat mass |
RU2011129812A (ru) | 2008-12-19 | 2013-01-27 | Нестек С.А. | Профилактика и лечение ротавирусной диареи |
CN102271534B (zh) | 2009-01-19 | 2014-07-09 | 雀巢产品技术援助有限公司 | 婴儿用营养组合物 |
US20100196341A1 (en) | 2009-02-05 | 2010-08-05 | Syngen Biotech Co., Ltd. | Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof |
EP2413952B2 (en) | 2009-04-03 | 2019-10-02 | Société des Produits Nestlé S.A. | Improvement in promotion of healthy catch-up growth |
PT2429539T (pt) | 2009-05-11 | 2017-01-12 | Nestec Sa | Lactobacilos johnsonii la1 ncc533 não replicativo (cncm i-1225) e distúrbios imunitários |
ES2382263T3 (es) | 2009-05-11 | 2012-06-06 | Nestec S.A. | Prevención y tratamiento de la diarrea alérgica |
EP2251031A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and neuronal health and development in the infant gut |
EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
WO2010143940A1 (en) | 2009-06-12 | 2010-12-16 | N.V. Nutricia | Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages |
EP2467032B1 (en) | 2009-08-18 | 2018-02-21 | Nestec S.A. | A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children |
US20110070334A1 (en) | 2009-09-20 | 2011-03-24 | Nagendra Rangavajla | Probiotic Stabilization |
EP2308498A1 (en) | 2009-09-30 | 2011-04-13 | Nestec S.A. | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life |
WO2011060123A1 (en) | 2009-11-12 | 2011-05-19 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
PL2520177T5 (pl) | 2009-12-29 | 2020-08-10 | Société des Produits Nestlé S.A. | Kompozycje odżywcze obejmujące płatki owocowe zawierające kwas dokozaheksaenowy |
BR112012023028B1 (pt) | 2010-03-12 | 2020-12-08 | Compagnie Gervais Danone | meio fermentado por uma cepa de bactéria de ácido láctico, composição e seu uso |
WO2011121379A1 (en) | 2010-03-30 | 2011-10-06 | Assistance Publique - Hopitaux De Paris | Use of bifidobacteria for preventing allergy in breastfed infants |
WO2011149335A1 (en) | 2010-05-25 | 2011-12-01 | N.V. Nutricia | Immune imprinting nutritional composition |
WO2011148221A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Lactic acid bacteria for maturation of the enteric nervous system in infants |
US20110293784A1 (en) | 2010-05-28 | 2011-12-01 | Anja Wittke | Milk-based nutritional compositions |
PL2593539T3 (pl) * | 2010-07-15 | 2017-07-31 | Compagnie Gervais Danone | Zastosowanie manganu do wzmacniania wzrostu bakterii L.Casei w mieszanych kulturach |
CN102021127B (zh) | 2010-07-28 | 2012-05-30 | 江南大学 | 一株副干酪乳杆菌及其应用 |
EP2436389A1 (en) | 2010-10-01 | 2012-04-04 | Nestec S.A. | Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof |
EP2449890A1 (en) | 2010-11-05 | 2012-05-09 | Nestec S.A. | Powdered cereal compositions comprising non-replicating probiotic microorganisms |
EP2449891A1 (en) | 2010-11-05 | 2012-05-09 | Nestec S.A. | Drinking yoghurt preparations containing non-replicating probiotic micro-organisms |
EP2455094A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect children against gastrointestinal infections |
EP2452572A1 (en) | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional formula with particularly adapted caloric density for infants and children |
EP2452573A1 (en) | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional composition with animal fats and vegetable fats |
EP2465507A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating skin diseases |
EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
EP2455387A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
EP2465508A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
MY160677A (en) | 2010-12-06 | 2017-03-15 | Nutricia Nv | Fermented infant formula |
US20130266688A1 (en) | 2010-12-08 | 2013-10-10 | Geraldine Ortega | Infant cereal products comprising hydrolyzed whole grain |
EP2465359A1 (en) | 2010-12-15 | 2012-06-20 | Nestec S.A. | Improved nutritional composition, especially for infants, with particular fat particles |
US20140371173A1 (en) | 2011-02-10 | 2014-12-18 | Nestec S.A. | Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk |
EP2690973B1 (en) | 2011-03-29 | 2016-03-23 | Nestec S.A. | Nutritional compositions having reduced sodium content and methods for making same |
EP2510932A1 (en) | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny |
EP2514435A1 (en) | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
EP2522232A1 (en) | 2011-05-13 | 2012-11-14 | Nestec S.A. | Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof |
US10039296B2 (en) | 2011-06-20 | 2018-08-07 | H.J. Heinz Company Brands Llc | Probiotic compositions and methods |
KR101261156B1 (ko) * | 2011-07-21 | 2013-05-07 | 에스케이씨앤씨 주식회사 | 비밀키 생성방법 및 이를 적용한 전자장치 |
PT2861242T (pt) | 2012-06-18 | 2018-11-07 | Heinz Co Brands H J Llc | Disfunções relacionadas com o glúten |
CA2911496C (en) | 2013-05-10 | 2023-08-22 | H.J. Heinz Company Brands Llc | Probiotics and methods of use |
-
2012
- 2012-06-18 US US14/127,573 patent/US10039296B2/en active Active
- 2012-06-18 BR BR112013032426-0A patent/BR112013032426B1/pt active IP Right Grant
- 2012-06-18 PL PL12803279T patent/PL2734049T3/pl unknown
- 2012-06-18 WO PCT/US2012/042959 patent/WO2012177556A2/en active Application Filing
- 2012-06-18 PT PT128032794T patent/PT2734049T/pt unknown
- 2012-06-18 CN CN201280040658.4A patent/CN103997899B/zh active Active
- 2012-06-18 EP EP18166007.7A patent/EP3366143A1/en active Pending
- 2012-06-18 MY MYPI2017001840A patent/MY187589A/en unknown
- 2012-06-18 MY MYPI2013702482A patent/MY171851A/en unknown
- 2012-06-18 TR TR2018/09987T patent/TR201809987T4/tr unknown
- 2012-06-18 RU RU2017129361A patent/RU2748839C2/ru active
- 2012-06-18 JP JP2014517052A patent/JP2014516589A/ja active Pending
- 2012-06-18 CA CA2839524A patent/CA2839524C/en active Active
- 2012-06-18 RU RU2014101392A patent/RU2630299C2/ru active
- 2012-06-18 DK DK12803279.4T patent/DK2734049T3/en active
- 2012-06-18 MX MX2013015175A patent/MX352677B/es active IP Right Grant
- 2012-06-18 AU AU2012273206A patent/AU2012273206B2/en active Active
- 2012-06-18 ES ES12803279.4T patent/ES2677850T3/es active Active
- 2012-06-18 EP EP12803279.4A patent/EP2734049B1/en active Active
-
2015
- 2015-01-06 HK HK15100105.5A patent/HK1199694A1/zh unknown
-
2016
- 2016-12-29 US US15/393,904 patent/US10251407B2/en active Active
-
2019
- 2019-03-21 US US16/360,154 patent/US11109603B2/en active Active
-
2020
- 2020-10-15 BR BR132020021160A patent/BR132020021160F1/pt active IP Right Grant
-
2021
- 2021-04-06 US US17/223,456 patent/US11771102B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0130228A1 (en) * | 1983-07-01 | 1985-01-09 | Microlife Technics, Inc. | Fermentation method using a selected lactobacillus |
US6599504B1 (en) * | 1997-12-08 | 2003-07-29 | Arla Ekonomisk Forening | Strain of bacteria of the species Lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain |
WO2007140622A1 (en) * | 2006-06-09 | 2007-12-13 | Nutravital Inc. | Dairy-derived probiotic compositions and uses thereof |
WO2008003782A1 (en) * | 2006-07-07 | 2008-01-10 | Alpro Nv | Method for preparing a dairy analogue |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103997899B (zh) | 益生菌组合物和方法 | |
TWI359668B (zh) | ||
ES2311729T5 (es) | Cepas probióticas, un procedimiento para la selección de ellas, composiciones de las mismas y su uso | |
CN105209050B (zh) | 益生菌和使用方法 | |
US20160303226A1 (en) | Heat-treated formulation of bifidobacterium lactis ncc 2818 reduces allergic manifestations | |
MXPA01009017A (es) | Cepas de lactobacillus capaces de evitar diarrea causada por bacterias patogenicas y rotavirus. | |
US20100158882A1 (en) | Immunomodulating probiotic lactic acid bacteria | |
EP2332557A1 (en) | Probiotic lactic acid bacteria | |
AU2017235999B2 (en) | Probiotic compositions and methods | |
NZ619099B2 (en) | Probiotic compositions and methods | |
MXPA01008976A (en) | Lactobacillus strains preventing diarrhoea pathogenic bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1199694 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1199694 Country of ref document: HK |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200427 Address after: Pennsylvania, USA Patentee after: Heinz brand Co., Ltd Address before: Pittsburgh, PA Patentee before: H.J. Heinz Company Brands LLC |